These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9469621)

  • 1. Enzyme-controlling medicines: introduction.
    Okamoto S; Hijikata-Okunomiya A; Wanaka K; Okada Y; Okamoto U
    Semin Thromb Hemost; 1997; 23(6):493-501. PubMed ID: 9469621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of argatroban, a selective thrombin inhibitor, on animal models of cerebral thrombosis.
    Tamao Y; Kikumoto R
    Semin Thromb Hemost; 1997; 23(6):523-30. PubMed ID: 9469624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N2-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl++ +) sulfonyl]-l-arginyl)]-2-piperidinecarboxylic acid.
    Kikumoto R; Tamao Y; Tezuka T; Tonomura S; Hara H; Ninomiya K; Hijikata A; Okamoto S
    Biochemistry; 1984 Jan; 23(1):85-90. PubMed ID: 6691968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety.
    Makhija N; Sarupria A; Kumar Choudhary S; Das S; Lakshmy R; Kiran U
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1201-7. PubMed ID: 24050855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geometry of binding of the benzamidine- and arginine-based inhibitors N alpha-(2-naphthyl-sulphonyl-glycyl)-DL-p-amidinophenylalanyl-pipe ridine (NAPAP) and (2R,4R)-4-methyl-1-[N alpha-(3-methyl-1,2,3,4-tetrahydro-8- quinolinesulphonyl)-L-arginyl]-2-piperidine carboxylic acid (MQPA) to human alpha-thrombin. X-ray crystallographic determination of the NAPAP-trypsin complex and modeling of NAPAP-thrombin and MQPA-thrombin.
    Bode W; Turk D; Stürzebecher J
    Eur J Biochem; 1990 Oct; 193(1):175-82. PubMed ID: 2226434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A NEW METHOD OF THE ANALYSIS OF EPSILON-AMINOCAPROIC ACID (EACA) AND AMINOMETHYLCYCLOHEXANE CARBOXYLIC ACID (AMCHA), THE POTENT ANTIFIBRINOLYTIC AGENTS].
    TAKATA Y; TAKATA A; OKAMOTO U
    Nihon Seirigaku Zasshi; 1964 May; 26():281-5. PubMed ID: 14172890
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic plasma concentrations of epsilon aminocaproic acid and tranexamic acid in horses.
    Fletcher DJ; Brainard BM; Epstein K; Radcliffe R; Divers T
    J Vet Intern Med; 2013; 27(6):1589-95. PubMed ID: 24118238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antinephritic effect of MD-805 [(2R, 4R) -4-methyl-[N2-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl) -L-arginyl] -2-piperidine-carboxylic acid monohydrate], a new antithrombin agent, on crescentic-type anti-GMB nephritis in rats].
    Suzuki Y; Yamada H; Ito M
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):463-73. PubMed ID: 6471586
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis of monomeric and polymeric conjugates carrying a thrombin inhibitor through an ester bond.
    Noguchi H; Iwata H; Ikada Y
    J Biomed Mater Res; 1998 Mar; 39(4):621-9. PubMed ID: 9492224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of plasma kallikrein selective inhibitors.
    Okada Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto U; Okamoto S
    Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of trypsin by (2R,4R)-4-phenyl-1-[Nalpha-(7- methoxy-2-naphthalenesulfonyl)-L-arginyl]-2-piperidinecarboxylic acid.
    Hijikata-Okunomiya A; Tamao Y; Kikumoto R; Okamoto S
    J Biol Chem; 2000 Jun; 275(25):18995-9. PubMed ID: 10748093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemostasis and antifibrinolytic therapy in major pediatric surgery].
    Schindler E; Hertfelder HJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2013 Jul; 48(7-8):454-61; quiz 462. PubMed ID: 23929163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarity and dissimilarity in the stereogeometry of the active sites of thrombin, trypsin, plasmin and glandular kallikrein.
    Hijikata-Okunomiya A; Okamoto S; Kikumoto R; Tamao Y; Ohkubo K; Tezuka T; Tonomura S; Matsumoto O
    Thromb Res; 1987 Mar; 45(5):451-62. PubMed ID: 2954262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifibrinolytics reduce blood loss in adult spinal deformity surgery: a prospective, randomized controlled trial.
    Peters A; Verma K; Slobodyanyuk K; Cheriyan T; Hoelscher C; Schwab F; Lonner B; Huncke T; Lafage V; Errico T
    Spine (Phila Pa 1976); 2015 Apr; 40(8):E443-9. PubMed ID: 25868100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preventative effect of the antifibrinolytic agents, epsilon-aminocaproic acid and tranexamic acid, on stress ulcer formation in rats.
    Kodama Y; Kumashiro R; Gain T; Matsumoto T
    Int Surg; 1983; 68(4):361-3. PubMed ID: 6668161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of tranexamic acid and ε-aminocaproic acid concentrations required to inhibit fibrinolysis in plasma of dogs and humans.
    Fletcher DJ; Blackstock KJ; Epstein K; Brainard BM
    Am J Vet Res; 2014 Aug; 75(8):731-8. PubMed ID: 25061704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of active center-directed plasmin and plasma kallikrein inhibitors and studies on the structure-inhibitory activity relationship.
    Teno N; Wanaka K; Okada Y; Taguchi H; Okamoto U; Hijikata-Okunomiya A; Okamoto S
    Chem Pharm Bull (Tokyo); 1993 Jun; 41(6):1079-90. PubMed ID: 8370108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New model for in vivo studies of pharmacological interventions with endogenous fibrinolysis: effects of thrombin inhibitors.
    Lenfors S; Gustafsson D
    Semin Thromb Hemost; 1996; 22(4):335-42. PubMed ID: 8944418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argatroban: a synthetic thrombin inhibitor of low relative molecular mass.
    Fitzgerald D; Murphy N
    Coron Artery Dis; 1996 Jun; 7(6):455-8. PubMed ID: 8889361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ε-aminocaproyl-S-benzyl-L-cysteine on the t-PA activity of human saliva.
    Midura-Nowaczek K; Kaczyńska J; Bruzgo I; Markowska A; Drozdowska D
    Adv Med Sci; 2011; 56(2):323-6. PubMed ID: 22037173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.